For over a decade, the influential National Comprehensive Cancer Network (NCCN) has been recommending that men with low-risk prostate cancer be offered active surveillance as the lone “preferred”
A potential new urine biomarker for prostate cancer not only spots the presence of aggressive tumors, it also indicates the amount of these tumors, according to a recent
CHICAGO ― The long-term side effects of hypofractionated postoperative prostate bed radiotherapy (HYPORT) for prostate cancer are similar to those of conventional radiotherapy, a new study concludes. “Hypofractionation
There will be “routine application” and “broader acceptance” of minimally invasive focal therapies for early-stage prostate cancer within the next 5 years in the United States, predict a
Opioids were prescribed most often for vitiligo, hemangioma, pemphigus, atopic dermatitis, and psoriasis, according to a study that used national ambulatory care data to evaluate pain medication use at
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. COMTAN® entacapone Consumer Medicine Information What is in this leaflet This leaflet answers some common
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
